Dose-finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double-blind, placebo-controlled trial.
about
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patientsRe-response to tolvaptan after furosemide dose reduction in a patient with refractory ascitesThe treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials.Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in JapanPredictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis.Tolvaptan for the treatment of liver cirrhosis oedema.Diuretic usage for protection against end-organ damage in liver cirrhosis and heart failure.Treatment for cirrhotic ascites.Predictive parameter of tolvaptan effectiveness in cirrhotic ascites.Efficacy of peritoneovenous shunt for treating tolvaptan-resistant refractory ascites in a cirrhotic patient with portal vein thrombosis: A case report.Efficacy of tolvaptan in patients with refractory ascites in a clinical settingSafety and efficacy of long-term tolvaptan therapy for decompensated liver cirrhosis.Effects of low-dose tolvaptan on electrolyte abnormality and hemodynamic parameters in a liver cirrhosis-associated portopulmonary hypertension patient: A case report.Therapeutic effects of short- and intermediate-term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosis.Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study.Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).Effectiveness and safety of tolvaptan in liver cirrhosis patients with edema: Interim results of post-marketing surveillance of tolvaptan in liver cirrhosis (START study).Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites.Management of refractory cirrhotic ascites: challenges and solutions
P2860
Q26778032-136E730A-590B-42B0-ABAA-B58B4DD6A915Q34093932-020D6021-C0DA-4C8A-AC05-7F2504881432Q35092574-95DF42F8-5F03-4475-AD24-B0DB0BBC27E1Q35657152-5F8AAE33-7AEA-44FB-9075-C73FE7B04AA2Q36118182-E190E65C-3696-4863-8731-5F9D4A813272Q37414345-94DC684D-E4B2-4657-8741-29FC67C90C58Q38200108-AD127F5C-D2FA-4590-BA8D-50838EEC2FA0Q38779628-7002D6AC-D64A-4273-B862-7239AB9EB13FQ38882366-4235134E-2091-40C8-82E9-74BC991FC790Q39321625-133D3E5F-B781-44A5-9EE8-D814B2D44F4DQ40496089-42B3C306-9F45-46F7-877D-D0E4D5266C3BQ40771170-90E0198E-A8D5-4E10-A1C9-286AB820C24FQ40783974-C2CA545E-D1E8-407D-8484-77EF1CC07196Q42329743-5163B4F0-BD86-45CC-B765-D49C69C300EAQ45853525-E254723F-B86A-480B-86E0-6F1F120B99B7Q47280183-3ED6152B-BC96-4A98-BF0F-12249F4B21B3Q49893436-553CDCA1-B79C-475A-B958-CBAFCDF8CE07Q50221452-68092E8C-877B-4735-983C-62CE249BBCBAQ50277167-F2B42610-B1D1-48E4-A981-67231C43EF02Q57407557-8C930030-14F7-4EC0-AEAA-7C999D8E8F0B
P2860
Dose-finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double-blind, placebo-controlled trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Dose-finding trial of tolvapta ...... ind, placebo-controlled trial.
@en
Dose-finding trial of tolvapta ...... ind, placebo-controlled trial.
@nl
type
label
Dose-finding trial of tolvapta ...... ind, placebo-controlled trial.
@en
Dose-finding trial of tolvapta ...... ind, placebo-controlled trial.
@nl
prefLabel
Dose-finding trial of tolvapta ...... ind, placebo-controlled trial.
@en
Dose-finding trial of tolvapta ...... ind, placebo-controlled trial.
@nl
P2093
P2860
P356
P1433
P1476
Dose-finding trial of tolvapta ...... ind, placebo-controlled trial.
@en
P2093
ASCITES Dose-Finding Trial Group
Akira Kaneko
Chitomi Hasebe
Isao Sakaida
Kiwamu Okita
Kozo Kajimura
Mitsuru Okada
Seiji Kawazoe
P2860
P356
10.1111/HEPR.12099
P577
2013-03-27T00:00:00Z